Cargando…

Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients

BACKGROUND: Prostaglandin E2 (PGE2) receptor 3 (EP3) regulates tumor cell proliferation, migration, and invasion in numerous cancers. The role of EP3 as a prognostic biomarker in endometrial cancer remains unclear. The primary aim of this study was to analyze the prognostic significance of EP3 expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Junyan, Trillsch, Fabian, Mayr, Doris, Kuhn, Christina, Rahmeh, Martina, Hofmann, Simone, Vogel, Marianne, Mahner, Sven, Jeschke, Udo, von Schönfeldt, Viktoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787529/ https://www.ncbi.nlm.nih.gov/pubmed/29416671 http://dx.doi.org/10.18632/oncotarget.23140

Ejemplares similares

Prostaglandin E2 Receptor 4 (EP4) Affects Trophoblast Functions via Activating the cAMP-PKA-pCREB Signaling Pathway at the Maternal-Fetal Interface in Unexplained Recurrent Miscarriage
por: Peng, Lin, et al.
Publicado: (2021)

Prostaglandin E(2) receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses
por: Ye, Yao, et al.
Publicado: (2018)

Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)
por: Ye, Yao, et al.
Publicado: (2020)

Comparison of Histone H3K4me3 between IVF and ICSI Technologies and between Boy and Girl Offspring
por: Yang, Huixia, et al.
Publicado: (2021)

KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro
por: Lin, Lili, et al.
Publicado: (2023)

The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients
por: Heidegger, Helene, et al.
Publicado: (2017)

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions
por: Peng, Lin, et al.
Publicado: (2021)

EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
por: Hester, Anna, et al.
Publicado: (2019)

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
por: Han, Nan, et al.
Publicado: (2021)

β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation
por: Czogalla, Bastian, et al.
Publicado: (2020)

The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
por: Dietlmeier, Sebastian, et al.
Publicado: (2020)

Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022)

Factors Influencing the In Vitro Maturation (IVM) of Human Oocyte
por: Yang, Huixia, et al.
Publicado: (2021)

Targeting Aberrantly Elevated Sialyl Lewis A as a Potential Therapy for Impaired Endometrial Selection Ability in Unexplained Recurrent Miscarriage
por: Ma, Zhi, et al.
Publicado: (2022)

H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
por: Han, Nan, et al.
Publicado: (2020)

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
por: Fraungruber, Patricia, et al.
Publicado: (2021)

Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only
por: Hertlein, Linda, et al.
Publicado: (2017)

COX-2-PGE(2)-EPs in gynecological cancers
por: Ye, Yao, et al.
Publicado: (2020)

MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
por: Eppich, Simon, et al.
Publicado: (2020)

Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer
por: Beyer, Susanne, et al.
Publicado: (2020)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2022)

EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
por: Semmlinger, Anna, et al.
Publicado: (2018)

EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer
por: Buchholz, Anna, et al.
Publicado: (2021)

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018)

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017)

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
por: Ditsch, Nina, et al.
Publicado: (2020)

Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs)
por: Lin, Lili, et al.
Publicado: (2021)

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients
por: Czogalla, Bastian, et al.
Publicado: (2018)

Nuclear expression of VDR and AHR is mutually exclusive in glandular cells in endometriosis
por: De Pascali, Francesco, et al.
Publicado: (2021)

Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI
por: Rogenhofer, Nina, et al.
Publicado: (2022)

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases
por: Ye, Yao, et al.
Publicado: (2017)

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients
por: Deuster, Eileen, et al.
Publicado: (2019)

Early Life Oxidative Stress and Long-Lasting Cardiovascular Effects on Offspring Conceived by Assisted Reproductive Technologies: A Review
por: Yang, Huixia, et al.
Publicado: (2020)

Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
por: Topalov, Nicole Elisabeth, et al.
Publicado: (2021)

First Evidence for a Role of Siglec-8 in Breast Cancer
por: Trebo, Anna, et al.
Publicado: (2021)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

Expression of the Carbohydrate Lewis Antigen, Sialyl Lewis A, Sialyl Lewis X, Lewis X, and Lewis Y in the Placental Villi of Patients With Unexplained Miscarriages
por: Ma, Zhi, et al.
Publicado: (2021)

Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer
por: Vogelsang, Tilman L. R., et al.
Publicado: (2021)

FAM111A Is a Novel Molecular Marker for Oocyte Aging
por: Yang, Huixia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ldoheteqea1otvfqdh5qm0hsu